3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
2
Status
Unknown
2
Sponsor Class
INDUSTRY
6
OTHER
2
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Conditions
Multiple Myeloma
1
Leukemia, Myeloid
1
Interventions
Cyclophosphamide
2042
Radiotherapy
1859
Cisplatin
1825
Carboplatin
1533
Gemcitabine
1434
Paclitaxel
1289
Bevacizumab
1270
Docetaxel
1202
pembrolizumab
1198
Oxaliplatin
1160
Capecitabine
1142
Fluorouracil
1061
Dexamethasone
971
Rituximab
919
Nivolumab
908
Magnetic Resonance Spectroscopy
862
Etoposide
839
Doxorubicin
823
Drug Therapy
792
Radiosurgery
776
Irinotecan
775
Cytarabine
736
fludarabine
716
Leucovorin
676
Lenalidomide
608
fludarabine phosphate
564
Temozolomide
552
Radiation
541
Filgrastim
540
Cetuximab
537
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Interventional
×
Sensitivity and Specificity
×
Clear all
NCT01864902
2016-01-28
CART33
Chinese PLA General Hospital
Phase 1/2
Unknown
10 enrolled
NCT01886976
2016-01-28
CART-138
Chinese PLA General Hospital
Phase 1/2
Unknown
10 enrolled